Propel Bio Management »

Telesat Corp Cl A Cl B shares owned by Propel Bio Management

Quarter-by-quarter ownership of Telesat Corp Cl A Cl B (TSAT) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Telesat Corp Cl A Cl B

Tip: Access up to 7 years of quarterly data

All positions including Telesat Corp Cl A Cl B held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telesat Corp Cl A Cl B by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 291k 10.43

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Telesat Corp Cl A Cl B

MHR Fund Management
Highland Capital Management Fund Advisors
Propel Bio Management
Simplify Asset Management
Tejara Capital
Garnet Equity Capital Holdings
Connor, Clark & Lunn Investment Management
Millennium Management
Citadel Advisors
Bank of America Corporation
A.R. Schmeidler & Co
Penserra Capital Management
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
Gts Securities

View all funds holding Telesat Corp Cl A Cl B